Visible transition gap
Follow-up, medication access, education, or ownership still breaks after discharge.
First design partnership
Cairava is preparing a focused heart-failure design partnership with a community hospital that wants to replace fragmented follow-through with a shared workflow and human-owned exception queue.
Designed together · measured honestly
Who this is for
The best first partner is not looking for a generic AI project. The team is ready to define one transition pathway and own the work around it.
Follow-up, medication access, education, or ownership still breaks after discharge.
A nursing, quality, case-management, or transition leader can align the working team.
The hospital is willing to begin with one approved pathway rather than a broad platform rollout.
Both teams can review the workflow, evidence, workload, and boundaries with candor.
A staged partnership
Each stage produces a reviewable artifact and a clear decision about what happens next.
Document current roles, touchpoints, packets, calls, systems, and unresolved loops.
Define patient-facing content, ownership, review gates, escalation rules, and success measures.
Use synthetic episodes to evaluate usability, accessibility, provenance, and operational fit.
Compare follow-through, barrier handling, ownership, workload, and loop closure against the baseline.
Shared work, explicit owners
Measure the workflow first
The primary measure is whether critical transition obligations are completed, resolved, or escalated on time while existing staff support more patients. Readmissions and mortality remain exploratory downstream outcomes.
Questions, clearly answered
No. It is a structured way to design and measure a transition workflow. Clinical and financial outcomes require appropriate study design, evidence review, and approval before public claims are made.
Timing is scoped with the hospital after discovery. Cairava does not publish a fixed implementation promise before the workflow, approvals, technical path, and participating teams are known.
A committed sponsor, pathway owners, access to the current workflow, clinical and security review, and time for the operating team to validate the design.
Workflow mapping, the transition prototype, pathway configuration, synthetic validation materials, implementation support, and an operational measurement framework within the agreed scope.
Bring the current state
Tell us about the hospital, the operational sponsor, and the handoff problem. No patient information is needed.